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Background: Elevated fatty acids contribute to the development of type 2 diabetes and affect skeletal muscle
insulin sensitivity. Since elevated intramuscular lipids and insulin resistance is strongly correlated, aberrant lipid
storage or lipid intermediates may be involved in diabetes pathogenesis. The aim of this study was to develop a
method to determine the dynamic metabolic fate of lipids in primary human skeletal muscle cells and in intact
mouse skeletal muscle. We report a simple and fast method to characterize lipid profiles in skeletal muscle using
thin layer chromatography.
Findings: The described method was specifically developed to assess lipid utilization in cultured and intact skeletal
muscle. We determined the effect of a pan-diacylglycerol kinase (DGK) class I inhibitor (R59949) on lipid metabolism
to validate the method. In human skeletal muscle cells, DGK inhibition impaired diacylglycerol (DAG) conversion
to phosphatidic acid and increased triglyceride synthesis. In intact glycolytic mouse skeletal muscle, DGK
inhibition triggered the accumulation of DAG species. Conversely, the DGK inhibitor did not affect DAG content
in oxidative muscle.
Conclusion: This simple assay detects rapid changes in the lipid species composition of skeletal muscle with
high sensitivity and specificity. Determination of lipid metabolism in skeletal muscle may further elucidate the
mechanisms contributing to the pathogenesis of insulin resistance in type 2 diabetes or obesity.
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Background
Dysregulation of lipid metabolism, leading to lipid content
modification as well as production of second messengers,
contribute to the pathogenesis of insulin resistance in type
2 diabetes and obesity. Following uptake in skeletal muscle,
free fatty acids (FFA) are converted to long-chain fatty
acyl-CoAs (LCACoAs), which can undergo several fates.
LCACoAs can be imported into the mitochondria and
used as substrates for β-oxidation, incorporated into tri-
glycerides, or serve as a source of second messengers,
such as diacylglycerol (DAG). In skeletal muscle from
obese humans [1,2], FFA oxidation capacity is reduced,
thereby leading to intramuscular triacylglycerol accu-
mulation [3,4]. In addition, an accumulation of second-
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unless otherwise stated.also contributes to muscle insulin resistance, thereby ex-
acerbating the severity of type 2 diabetes [5-7]. For example,
DAG accumulation activates specific protein kinase C iso-
form activity and impairs insulin-stimulated glucose trans-
port through enhanced IRS-1 serine phosphorylation [8].
Understanding how FFA levels impact glucose metabolism
may elucidate the role of lipids in the pathogenesis insulin
resistance in type 2 diabetes or obesity. Here, we present a
simple and fast method to characterize the metabolic fate
of lipids in skeletal muscle using a thin layer chromatog-
raphy system (TLC).
Primary human skeletal muscle cell culture
Satellite cells were isolated from vastus lateralis skeletal
muscle biopsies derived from healthy volunteers by trypsin-
EDTA digestion, as previously described [9]. All partici-
pants provided written informal consent and all protocols
were approved by the Karolinska Institutet ethics commit-
tee. Myoblasts were propagated in growth medium (F12/
DMEM, 20% FBS, 1% PeSt and 1% fungizone (Invitrogen,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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serum medium (DMEM containing 1 g/l glucose, 2% FBS,
1% PeSt and 1% Fungizone). Experiments were performed
on differentiated myotubes cultured in 6-well plates. Final
experiments were conducted 7 days after differentiation
was induced.
Cultured primary human skeletal muscle cells were
incubated with 0.2 μCi/ml [14C(U)] palmitate (Perkin
Elmer, CA, USA) with non-radioactive palmitate (25 nM)
for 6 hours in the presence or absence of the DAG kinase
inhibitor (R59949, Calbiochem, Merck AB, Sweden). Fol-
lowing the incubation step, cells were washed 3 times with
cold PBS in order to remove the free and membrane-
bound radioactive palmitate.Figure 1 Schematic representation of lipid extraction and TLC develo
identify lipid species in primary human skeletal muscle cells and intact murMouse muscle incubation
Male C57BL/6 mice were purchased from Charles River
(Germany). Mice were housed on a 12 hour light/dark
cycle and received ad libitum standard rodent chow. Ex-
periments were approved by the Regional Animal Ethical
Committee (Stockholm, Sweden).
Mice (12–14 weeks old) were fasted for 4 hours prior
to the study. Mice were anesthetized intraperitoneally
with Avertin (2,2,2-tribromoethanol and tertiary amyl al-
cohol) at a volume of 10 μl/g body weight. Extensor digi-
torum longus (EDL) and soleus muscles were carefully
dissected without stretching and gently removed with
tendons intact. Muscles were incubated for 30 minutes
at 30°C in vials containing pre-oxygenated (95% O2, 5%pment. The outlined protocol was established to extract, separate and
ine skeletal muscles.
Figure 2 Representative image of the separation of the
standards. Triglycerides (Lane 1), phosphatidic acid (Lane 2), free
fatty acids (Lane 3), 1,2-DAG (Lane 4) and 1,3-DAG (Lane 5).
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15 mM mannitol, 5 mM glucose, 3.5% fatty acid-free bo-
vine serum albumin and 0.3 mM palmitate. Muscles
were then transferred to new vials containing fresh pre-
gassed KHB, supplemented as described above contain-
ing 2.5 μCi/ml of [14C(U)]-palmitate, and incubated for
120 min in the presence or absence of 25 μM DAG kin-
ase inhibitor (R59949). At the end of the incubation,
tendons were removed from muscles, which were rap-
idly weighed, immediately frozen in liquid nitrogen, and
stored at −80°C.
Lipid extraction
Cultured cells were scraped directly from plates in 300 μl
of an isopropanol/ 0.1% acetic acid mixture. Frozen mus-
cles were disrupted in the same buffer using the TissueLy-
ser II (Qiagen). The samples were incubated overnight at
room temperature with slight shaking to allow lipids to
diffuse into the solvent. Next, 600 μl of hexane and 150 μl
of 1 M KCl were added to each sample. The hexane-
isopropanol system is particularly suitable for extraction
of hydrophobic lipids, such as free fatty acids, triglycerides
and cholesterol esters [10]. Addition of KCl is designed
to improve the removal of non-lipid contaminants [11],
including proteins and amino acids. Samples were then
rotated for 10 minutes at room temperature. Tubes
were stored upright for 5 minutes to induce phase sep-
aration. The organic phase (upper phase) was collected
(~600 μl) and transferred to a new tube. The organic
phase was dried using a vacuum pump for 1 hour. Alter-
natively, nitrogen steam could be used to dry the lipids.
The lipid pellet was eluted in 50 μl of 1:1 methanol:
chloroform.
Detection of lipid species with thin layer chromatography
TLC plates that contain a concentration zone and are
channeled were selected to facilitate the loading of lipid
extracts (Silica Gel G 250 μm 20×20 cm, Analtech, DE,
USA). One hour before the development of the TLC plate,
the loading chamber was filled with 100 ml of a hexane:
diethylether:acetic acid mixture (80:20:3). The lid of the
chamber was then sealed using high-vacuum grease
(Corning, NY, USA) to allow vapor to accumulate in the
chamber. The lipid suspension was then applied to the
TLC plate at ~2 cm from the bottom (on the preadsorbant
zone) and separated in the hexane:diethylether:acetic acid
system for 30 minutes. The compounds 1,2-Dioctanyl
[1-14C] rac-glycerol (1,2-DAG), 1,3-Dioleoyl-rac-glycerol
[oleoyl-1-14C] (1,3-DAG) (American Radiolabeled Chemi-
cals Inc, MO, USA), [U-14C]palmitate (Perkin Elmer), and
[14C]triolein (TG) were used as standards. Plates were
dried for 5–10 minutes (until all solvents evaporated) and
wrapped in plastic foil. The wrapped plate was transferred
to an exposure cassette (GE Healthcare) and exposedto an X-ray film. The cassette was also wrapped with
plastic in order to avoid moisture damage and was
stored at −80˚C overnight.
Quantification
After overnight incubation, the cassette was removed
from −80˚C and allowed to stand at room temperature
for 1 hour. The X-ray film was developed using an X-ray
developer machine. Quantification by densitometry was
performed using Quantity One software (Biorad).
Detection of fatty acid oxidation with 3H-palmitate
In addition to lipid intermediates, the described protocol
can also be used to simultaneously detect fatty acid oxida-
tion, through the addition of 3H-palmitate along with
14C-palmitate at the same time. For this, the TLC plate
should be sprayed with an autoradiographic enhancer
spray (EN3HANCE, Perkin Elmer) prior to X-ray film
exposure. Application of EN3HANCE should be repeated
3 times for 10 seconds, with complete drying of the TLC
plate following each round. This spray allows the detec-
tion of lowly abundant species and can reduce the time
necessary for sufficient exposure. Fatty acid oxidation is
measured by the release of 3H2O in the media [12].
Results and discussion
A schematic representation of the protocol used to iden-
tify lipid species in skeletal muscle by TLC is described in
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origin is shown in Figure 2. Phosphatidic acid cannot
enter the plate and appears at the origin, while 1,2-DAG
migrated a few millimeters above the origin. The two dis-
tinct bands of 1,3-DAG are visible at 2 and 3 cm above
the origin, due to the conformation of the lateral chains.
Palmitic acid and triglycerides migrated at 6 cm and 9 cm,
respectively, from the origin. The characterization of the
lipid standard profile is crucial, since standards can beFigure 3 Lipid profile in cultured human skeletal muscle cells. Represe
cells with lipid standards: FFA (palmitate), phosphatidic acid (PA), diacylglyc
triglycerides (B), 1,2-DAG (C), 1,3-DAG (D) in absence (Ctrl: control) or prese
performed in duplicate. *p < 0.05 versus control. Results are means ± SEM.pooled together in one lane to allow more samples to be
run on the same plate.
Exposure of primary human muscle cells to 14C-
palmitate for 6 hours produced a lipid migration pattern
as shown in Figure 3A. To further validate the sensitiv-
ity and specificity of this system, primary human muscle
cells were treated with a specific DAG kinases inhibitor
(R59949; Figure 3B-D). DGK inhibition increased by
31% 1,3-DAG (Figure 3C) and by 30% percent triglyceridesntative image of the lipid profile in cultured human skeletal muscle
erol (1,2- and 1,3-DAG) and triglycerides (TG) (A). Quantification of
nce of DGK inhibitor (R59949). n = 3 independent experiments
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human myotubes, which reflects an impaired DAG con-
version to phosphatidic acid. This result is consistent
with previous published work [13], confirming the sen-
sitivity of the assay. Different exposure times can be easily
selected to quantify different lipid species according to
their abundance.
The metabolic fate of free fatty acids was also deter-
mined in intact mouse skeletal muscle (Figure 4A).
Treatment of mouse glycolytic EDL skeletal muscle with
a DGK inhibitor led to an accumulation of 1,3-DAG spe-
cies (Figure 4D). However the DGK inhibitor did not
alter 1,3-DAG species in oxidative soleus muscle. In
contrast to human cells, triglyceride synthesis in mouseFigure 4 Lipid profile in intact mouse skeletal muscle. Representative i
or in presence of a diacylglycerol kinase inhibitor (Ctrl: Control ; R59949: DG
diacylglycerol (1,2- and 1,3-DAG) and triglycerides (TG) are used as standard
(D) in absence (Ctrl: control) or presence of DGK inhibitor (R59949). n = 5. *EDL muscle remained unchanged after incubation with
the DGK inhibitor (Figure 4C), possibly due to a reduced
incubation time.Conclusion
Different systems exist to explore cellular lipid profiles in
various biological systems, including high-performance li-
quid chromatography, gas chromatography, and mass spec-
trometry. TLC is a convenient system that allows simple
and easy determination and quantification of lipid species.
The equipment required for TLC is quite inexpensive and
the experimental procedure can be quickly established in
most laboratory environments.mage of the lipid profile in mouse EDL and soleus muscle in absence
K inhibitor) (A). Free fatty acids (FFA), phosphatidic acid (PA),
s. Quantification of free fatty acids (B), triglycerides (C) and 1,3-DAG
p < 0.05 versus control. Results are means ± SEM.
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been reviewed earlier [14,15]. Lipid extraction using iso-
propanol/hexane was first used by Hara and Radin [11]
as an alternative to chloroform/methanol extraction and
extracts a high percentage of the lipids with low protein
contamination. Moreover, use of plastic materials is pos-
sible with this extraction procedure. The possibility to use
alternative TLC buffer systems allows the user to specific-
ally separate the lipid species of interest [16,17]. Finally,
the use of a single mobile phase permits simultaneous
comparisons of multiple samples. Hence, this method pro-
vides an easy and rapid evaluation of how exogenous com-
pounds influence lipid metabolism.
In developing the current TLC protocol, radioactive
palmitate was used as a convenient, inexpensive, and
available physiological substrate. Due to the great diver-
sity in fatty acid structure, with varying chain length or
degree of saturation, different substrates (e.g. oleate,
myristate, laurate) can assume distinct fates. Therefore,
different radiolabeled fatty acids can be used in the same
TLC system in order to examine the effects of exogen-
ous compounds on lipid abundance. In conclusion, this
method allows for the easy, fast and efficient detection
of changes in lipid metabolism in both cultured and in-
tact skeletal muscle. Moreover, this method can readily
be extrapolated to other cell types and tissues such as
brain, heart, liver or smooth muscle.
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